Ophthotech Corp (OPHT) Misses Q2 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Ophthotech Corp (OPHT) Misses Q2 EPS by 6c

Ophthotech Reports Second Quarter 2015 Financial and Operating Results

August 5, 2015 7:30 AM EDT

Conference Call and Webcast Today, August 5, 2015, at 8:00 a.m. ET

NEW YORK--(BUSINESS WIRE)-- Ophthotech Corporation (Nasdaq: OPHT) today announced financial results for the second quarter ended June 30, 2015 and provided an update on the Companys business and product development programs.

Program Highlights

In May 2015, Ophthotech provided updates on the Companys two Phase 3 trials of Fovista® in combination with Lucentis® (ranibizumab) in patients with wet Age-Related Macular Degeneration (AMD). Completion of enrollment of the first Phase 3 trial was announced. In... More